Trademark: 88308511
Status Date
Tuesday, November 24, 2020
Registration Number
6206397
Registration Date
Tuesday, November 24, 2020
Filing Date
Wednesday, February 20, 2019
Published for Opposition
Tuesday, July 2, 2019
44 Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
42 Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
Jan 29, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 29, 2021
Teas Change Of Correspondence Received
Jan 29, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 29, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 29, 2021
Teas Change Of Owner Address Received
Nov 24, 2020
Registered-Principal Register
Oct 22, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 21, 2020
Allowed Principal Register - Sou Accepted
Oct 21, 2020
Teas/Email Correspondence Entered
Oct 21, 2020
Correspondence Received In Law Office
Oct 13, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 13, 2020
Teas Change Of Correspondence Received
Oct 13, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 13, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 13, 2020
Teas Change Of Owner Address Received
Oct 13, 2020
Teas Response To Office Action Received
Sep 11, 2020
Notification Of Non-Final Action E-Mailed
Sep 11, 2020
Non-Final Action E-Mailed
Sep 11, 2020
Su - Non-Final Action - Written
Aug 13, 2020
Statement Of Use Processing Complete
Jul 31, 2020
Use Amendment Filed
Aug 12, 2020
Case Assigned To Intent To Use Paralegal
Jul 31, 2020
Teas Statement Of Use Received
Jul 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 8, 2020
Teas Change Of Correspondence Received
Jul 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2020
Teas Change Of Owner Address Received
Apr 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2020
Extension 1 Granted
Apr 22, 2020
Extension 1 Filed
Apr 22, 2020
Teas Extension Received
Oct 22, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 11, 2019
Extension Of Time To Oppose Process - Terminated
Aug 14, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 14, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 31, 2019
Extension Of Time To Oppose Received
Jul 2, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 2, 2019
Published For Opposition
Jun 12, 2019
Notification Of Notice Of Publication E-Mailed
May 29, 2019
Assigned To Lie
May 15, 2019
Approved For Pub - Principal Register
May 15, 2019
Examiner's Amendment Entered
May 15, 2019
Notification Of Examiners Amendment E-Mailed
May 15, 2019
Examiners Amendment E-Mailed
May 15, 2019
Examiners Amendment -Written
May 1, 2019
Assigned To Examiner
Mar 12, 2019
New Application Office Supplied Data Entered In Tram
Feb 23, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
